Mendis S, Davis S, Norrving B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015;46(5):e121–2.

Article  PubMed  Google Scholar 

Chapman MJ. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Ther. 2006;111(3):893–908.

Article  PubMed  CAS  Google Scholar 

Seidah NG, Garçon D. Expanding biology of PCSK9: roles in atherosclerosis and beyond. Curr Atheroscler Rep. 2022;24(10):821–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Almeida SO, Budoff M. Effect of statins on atherosclerotic plaque. Trends Cardiovasc Med. 2019;29(8):451–5.

Article  PubMed  CAS  Google Scholar 

Silverman MG, Ference BA, Im K, et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA. 2016;316(12):1289–97.

Article  PubMed  CAS  Google Scholar 

Abdul-Rahman T, Bukhari SMA, Herrera EC, et al. Lipid lowering therapy: an era beyond statins. Curr Probl Cardiol. 2022;47(12): 101342.

Article  PubMed  Google Scholar 

Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395–410.

Article  PubMed  CAS  Google Scholar 

Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109(48):19751–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014;1841(7):919–33.

Article  PubMed  CAS  Google Scholar 

Stitziel NO, Khera AV, Wang X, et al. ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol. 2017;69(16):2054–63.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dewey FE, Gusarova V, Dunbar RL, et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med. 2017;377(3):211–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hu X, Fan J, Ma Q, et al. A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease. J Nanobiotechnol. 2022;20(1):237.

Article  CAS  Google Scholar 

Hada Y, Uchida HA, Mukai T, et al. Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice. Clin Sci (Lond). 2020;134(20):2771–87.

Article  PubMed  CAS  Google Scholar 

Cuchel M, Raal FJ, Hegele RA, et al. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023;44(25):2277–91.

Article  PubMed  PubMed Central  Google Scholar 

Mai W, Liao Y. Targeting IL-1β in the Treatment of Atherosclerosis. Front Immunol. 2020;11: 589654.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–147.

Article  PubMed  CAS  Google Scholar 

Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47(8):600–11.

Article  PubMed  CAS  Google Scholar 

Buckley LF, Abbate A. Interleukin-1 blockade in cardiovascular diseases: a clinical update. Eur Heart J. 2018;39(22):2063–9.

Article  PubMed  CAS  Google Scholar 

Orecchioni M, Kobiyama K, Winkels H, et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science. 2022;375(6577):214–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chi H, Messas E, Levine RA, Graves DT, Amar S. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation. 2004;110(12):1678–85.

Article  PubMed  CAS  Google Scholar 

Isoda K, Sawada S, Ishigami N, et al. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2004;24(6):1068–73.

Article  PubMed  CAS  Google Scholar 

Huang Y, Ma K, Qin R, Fang Y, Zhou J, Dai X. Pristane attenuates atherosclerosis in Apoe(-/-) mice via IL-4-secreting regulatory plasma cell-mediated M2 macrophage polarization. Biomed Pharmacother. 2022;155: 113750.

Article  PubMed  CAS  Google Scholar 

Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23(4):656–60.

Article  PubMed  CAS  Google Scholar 

Van Tassell BW, Trankle CR, Canada JM, et al. IL-1 blockade in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2018;11(8): e005036.

Article  PubMed  PubMed Central  Google Scholar 

Van Tassell BW, Canada J, Carbone S, et al. Interleukin-1 blockade in recently decompensated systolic heart failure: results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail. 2017;10(11): e004373.

Article  PubMed  PubMed Central  Google Scholar 

Wu C, Mao J, Wang X, et al. Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis. J Nanobiotechnology. 2023;21(1):271.

Article  PubMed  PubMed Central  Google Scholar 

Mali VR, Palaniyandi SS. Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic Res. 2014;48(3):251–63.

Article  PubMed  CAS  Google Scholar 

Hu R, Dai C, Dong C, et al. Living macrophage-delivered tetrapod PdH nanoenzyme for targeted atherosclerosis management by ROS scavenging, hydrogen anti-inflammation, and autophagy activation. ACS Nano. 2022;16(10):15959–76.

Article  PubMed  CAS  Google Scholar 

Gimbrone MA Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33.

Article  PubMed  CAS  Google Scholar